All Activity

You actually get to play interior designer, choosing Papa's Games furniture that affects how much customers tip or how long they’re willing to wait.

It's which means that amazing together with inspiring. We really enjoy any designs together with whoever should get it all during the post shall be grinning. 해외선물 분양

Minnesota lawmakers have approved a bill that would legalize the regulated therapeutic use of psilocybin for adults 21 and older, while rescheduling the psychedelic under state statute. Members of the House Health Finance and Policy Committee on Monday passed the legislation from Rep. Andy Smith (DFL) in a voice vote. The proposal next heads to the Commerce Finance and Policy Committee. Smith also sponsored a similar measure last year that did not ultimately advance to enactment. Under the current bill, which was revised with a substitute amendment at the committee hearing, qualified patients 21 and older could receive psilocybin-assisted therapy in an “approved private residence or at a licensed treatment facility,” according to a summary from the Minnesota House Research Department. “No one in this committee, I know, questions the fact that mental illness is one of the defining issues in our society today,” Smith, who described the legislation as responsive to recommendations from a state psychedelics task force that was formed under a separate law, said. “Today in this committee, we are talking about a new tool: A therapeutic psilocybin program here in Minnesota that has great potential.” “It will help Minnesotans who are struggling with a wide variety of mental illnesses from substance use disorder, depression, PTSD, anxiety, chronic pain and more,” he said, before describing the key provisions of the proposed legislation. A registered facilitator would need to administer the psychedelic. To start, the program would need to involve licensing 20 to 50 facilitators, with at least three approved testing facilities for psilocybin. No more than 1,000 patients could participate in the psychedelic therapy for the first three years of the law’s implementation. The Department of Health (DOH) and Office of Cannabis Management (OCM) would be responsible for overseeing the program and establishing rules, with the heath commissioner also tasked with collaborating with a newly established Psychedelic Medicine Advisory Committee on the initiative. Psilocybin sessions would involve “preparation” with a patient-facilitator consultation, “administration” where patients would receive the psychedelic and “integration” where patients would work with professionals to process the therapeutic experience. Further, HF 2906 as amended incorporates protections for health professionals that help facilitate the program. And it would impose penalties for violations of the law such as the unsanctioned administration or cultivation of psilocybin outside of the parameters of the program. “I think a lot of the when somebody hears about this initially and thinks, ‘Hey, medicinal cannabis program’—a lot of criticism that is ‘Oh, it’s the nose under the camel’s tent for legalization’ or whatnot,” Rep. Nolan West (R), who is cosponsoring the legislation, said. “This is a pilot program.” The lawmaker also pointed out that interest in the therapeutic potential of psychedelics extends not just across party lines but all the way up to the White House, where U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. and other administration officials have discussed expanding access to the novel therapies. In addition to creating the psilocybin therapy program, the Minnesota bill calls for the psychedelic to be moved from Schedule I to Schedule IV of the state’s controlled substances list, reflecting a low abuse potential and low risk of dependency. One of the open questions for the reform is how to ensure it will receive adequate funding, and so while the sponsor said he isn’t expecting significant political resistance to the underlying purpose of the legislation, it’s possible spending concerns could prove problematic. “If it doesn’t happen this year, I feel very confident in the next budget year that we’ll be able to get this done,” Smith told The Minnesota Star Tribune. Kurtis Hanna, board president for the Psychedelic Access Project, told Marijuana Moment that the advancement of the bill through committee with a bipartisan vote is “encouraging” when “the Minnesota legislature is as divided as ever.” “Veterans, mental health practitioners, doctors and patients came out in full force today to support providing another tool in the toolbox to Minnesotans suffering from mental health issues,” he said. “I’m excited to see this issue gain more traction as it moves through the next few committee stops on its way to a full vote in the House and Senate.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile in Minnesota, the state’s first government-run marijuana retailer recently opened its doors, marking another milestone in the state’s adult-use cannabis program. Last September, Minnesota officials granted the state’s first-ever marijuana event organizer license, allowing adults to buy and consume cannabis products on-site at a festival. The first non-tribal marijuana shops opened for sales to adults 21 and older earlier that month. Also last year, the Minnesota city of Eden Prairie sought suggestions from residents on what to name a new, government-branded cannabis gummy product to be sold at municipal liquor stores. Minnesota’s House of Representatives circulated a poll at last year’s State Fair that asked attendees about the idea of allowing localities to enact bans on marijuana businesses within their borders. Most respondents who have an opinion on the issue agree with the policy, despite it not currently being a part of the state’s cannabis laws. Ahead of the enactment of legalization in Minnesota, lawmakers’ separate State Fair polls found majority support for the reform. The governor has also selected a top cannabis regulator for the state who will oversee the adult-use market rollout. Last June, June, OCM issued the state’s first recreational marijuana license for a cultivation microbusiness. OCM said at the time that it’s taking further steps to build up in the industry and create opportunities to entrepreneurs, including opening a new licensing window for cannabis testing facilities, accepting the first applications for marijuana event licenses and verifying more social equity status requests. Separately, after Minnesota lawmakers passed a bill to end the criminalization of bong water containing trace amount of drugs, the governor signed the measure into law last May. The change addresses an existing policy that had allowed law enforcement to treat quantities of bong water greater than four ounces as equivalent to the pure, uncut version of whatever drug the device was used to consume. Meanwhile, Minnesota Gov. Tim Walz (D) said in December that the state is “exploring” how to respond to an impending federal ban on hemp THC products, which would be “very disruptive” to a “thriving industry.” Image courtesy of CostaPPR. The post Minnesota Lawmakers Approve Bill To Legalize Psilocybin Therapy And Reschedule The Psychedelic Under State Law appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Texas officials have adopted a series of new rules for the state’s hemp market—with certain revisions that advocates and stakeholders call a “direct victory,” including changes to make participation in the industry more affordable, and other regulations that threaten to severely restrict product availability. The Department of State Health Services (DSHS) unveiled the amended hemp rules on Friday, about two months after publishing proposed regulations with licensing fees and other changes that led organizations such as the Texas Cannabis Policy Center (TCPC) to sound the alarm. In response, the department received more than 1,400 comments urging revisions. “Revised rules have slashed manufacturer fees from $25,000 to $10,000 and retailer fees from $20,000 to $5,000. This is a direct victory for advocacy,” Heather Fazio, director of TCPC, said in an email to supporters on Monday. “However, significant challenges remain.” Specifically, the agency decided to maintain language requiring hemp products to be tested for “total THC” content, including THCA, which means most cannabis flower would be considered non-compliant with limitations imposed under state law. “We estimate this will hand 50 percent of the legal market to illicit operators, making our state less safe,” Fazio said. TCPC and other groups such as the Texas Hemp Business Council (THBC) have also pointed out that there would be additional requirements imposed on hemp businesses with respect to product testing, labeling and record-keeping. The Texas Department of State Health Services has adopted new rules for consumable hemp products under Chapter 300. Key takeaways from our initial review: • Manufacturer licenses: $10,000 per facility • Retail licenses: $5,000 per location • THCA now included in total THC… — Texas Hemp Business Council (@TexasHempBiz) March 7, 2026 Separately, under a proposed rule from the Texas Alcoholic Beverage Commission (TABC) there would also be a “less consequential, but important” update to the hemp program, Fazio said, with the agency seeking to prohibit the on-site consumption of hemp at businesses where alcohol isn’t allowed. There would be no “sampling” exceptions in place, either. (Disclosure: Fazio supports Marijuana Moment’s work with a monthly Patreon pledge.) TCPC did share a piece of positive news for advocates, noting “steady progress” in expanding the state’s medical cannabis program under a law enacted last year. While adult-use legalization has continued to stall in the conservative legislature, the medical marijuana program is significantly expanding, with nine new licenses already approved and three more expected before April 1. Meanwhile, last week, Texas voters approved a marijuana legalization question that appeared on the state’s Democratic primary ballot. As part of the primary election on Tuesday, each major party was able to place several non-binding propositions on the ballot that allow voters show how they feel on key issues. The Texas Democratic Party used one of its propositions to find out where the electorate stands on legalizing cannabis and whether past convictions should be expunged. For what it’s worth, a statewide poll released last month found that Texas voters don’t like how state leaders and lawmakers have handled marijuana and THC policy issues. In the survey, a plurality of voters (40 percent) said they disapprove of how their elected officials have approached the issue, according to the survey. Just 29 percent said they approve of how cannabis issues have been handled, while 31 percent said they didn’t have an opinion one way or another. A separate poll released last year found that a plurality of Texas voters want the state’s marijuana laws to be made “less strict.” And among the legislative items lawmakers considered during recent special sessions, voters say a proposal to address hemp regulations was among the least important. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — For its part, the state Department of Public Safety in October adopted additional rules to increase the number of licensed dispensaries, establishing security requirements for “satellite” locations and authorizing the revocation of licenses for certain violations. DSHS also recently finalized rules allowing doctors to recommend new qualifying conditions for cannabis patients and creating standards for allowable low-THC inhalation devices. Meanwhile, bipartisan Texas lawmakers say the stage is set to advance legislation next session establishing regulations for hemp THC products, with growing understanding among their colleagues that prohibition fails to effectively address concerns about the cannabis market. The post Texas Officials Unveil Amended Hemp Rules With Strict ‘Total THC’ Limits But Lower Licensing Fee Than Previously Floated appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Virginia lawmakers have passed a bill to protect the rights of parents who use marijuana in compliance with state law. The legislation from Del. Nadarius Clark (D) cleared both the Senate and House of Delegates last week in amended form. It now heads to Gov. Abigail Spanberger (D). The bill is consistent with a measure Clark sponsored last session that advanced through the legislature, only to be vetoed by then-Gov. Glenn Youngkin (R). The current proposal states that a “person’s legal possession or consumption of substances…alone shall not serve as a basis to restrict custody or visitation unless other facts establish that such possession or consumption is not in the best interest of the child.” The bill also specifies that a parent or legal guardian can’t be construed to have failed a drug test over legal substances such as cannabis. “HB 942 is a bill that states no parent shall lose their child custody or visitation for the sole legal possession or consumption of authorized substances,” Clark said on the House floor on Friday when urging the body to approve the Senate’s changes to his legislation. “The Senate put a substitution on this bill because there’s a current study going on a certain part of the code section, so we didn’t want to touch that until the study is complete.” Youngkin, the former governor, claimed in his veto message last year that the prior measure introduced “unnecessary complications and risks exposing children to harm.” “The bill disregards clear evidence linking substance use to child endangerment, particularly in the wake of increased incidents of children ingesting cannabis-infused substances following the legalization of marijuana,” he argued. “By broadly prohibiting courts from considering parental marijuana use in custody and visitation determinations, [the bill] risks prioritizing drug use over the health and well being of children.” The then-governor also vetoed an even earlier version of the bill in 2024. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — While Spanberger, the current governor, hasn’t specifically weighed in on the parental rights legislation, she is generally more supportive of marijuana reform than her predecessor and backs legalizing recreational cannabis sales, which Youngkin also vetoed. Legislation to legalize and regulate the adult-use marijuana market is also advancing toward the governor’s desk this session. The House and Senate passed differing versions of the reform and a bicameral conference committee has been appointed to negotiate a single proposal to send to Spanberger. Virginia lawmakers have additionally sent the governor legislation to provide a pathway to resentencing for people with prior marijuana convictions. Legislation to allow patients to access medical cannabis in hospitals is also set for Spanberger’s action. The post Virginia Bill To Protect Rights Of Parents Who Use Marijuana Heads To Governor’s Desk appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A GOP congressman running for governor in Florida who has opposed marijuana legalization in the state and sponsored federal legislation to upend a Washington, D.C. sentencing reform law has admitted for the first time that he was arrested for selling cannabis as a young adult. Rep. Byron Donalds (R-FL), a Trump-endorsed GOP candidate vying to replace Florida Gov. Ron DeSantis (R), was pressed on the apparent disconnect during an interview with CBS Miami that aired on Saturday. While it was previously known that Donalds faced an arrest over marijuana in 1997—only to have the charges dropped years later as part of a pre-trial diversion program—this marked the first time he’s publicly admitted to selling small amounts of cannabis and acknowledged that he benefitted from the type of criminal justice reform law he’s worked to undermine in the District of Columbia. “Honestly, I was walking down the street, I was leaving a party, officers came up, asked me if I would empty my pockets. I said, ‘Yes, of course.’ I had a dime bag of marijuana in my pocket. That’s the story,” the congressman said. “It was bad decisions. I can’t undo that decision.” Donalds said he sold “low-level amounts” of marijuana, reiterating that he made “terrible decisions” and that it was among the things he did in his early adulthood that he wishes he could “undo.” “I wish I could undo [it]. I wish I could, but I can’t do that,” he said. “I would tell people, if you examine my life since 20 years old, my life has really been a story of redemption.” But that redemption arc was made possible, in part, thanks to sentencing policy that afforded Donalds a level of relief that he’s sought to deprive D.C. residents of—a point that Rep. Jasmine Crockett (D-TX) raised during a House floor debate last year where she slammed her GOP colleague over the apparent double standard. “Imagine standing in front of a judge with your life hanging in balance, and instead of prison you’re given a promise of mercy. Your record is wiped clean, and you’ve got a second chance at life,” Crockett said. “Imagine turning that into a promotion and you go to college and get a job and even become a member of Congress. That’s what redemption looks like.” “That’s what America is supposed to be about. And that is exactly the story of the next wannabe governor from Florida, as a young man, he went through,” she said, referring to Donalds. Donalds, who also took a stand against a Florida marijuana legalization ballot initiative in 2024 and argued the issue should be up to the legislature to decide, said during his latest interview that he will “never say that the decisions I made when I was very young were right decisions or smart decisions.” “They were terrible decisions—desperate decisions—but in Florida, I had to face the music as an adult. In D.C., they were letting 20 or four year olds be tried as juveniles. That’s not right,” he said. “In Florida, I had to face the music as an adult, not as a juvenile. Now, Florida does have laws around diversion—being able to seal records—and yes, those were things that were afforded to me. And I look back on those days and I say, ‘You know what? That helped me restart my life. So be it.’ But in D.C., it was very different.” Donalds has also raised eyebrows after acknowledging that there’s “a trace of racism” in marijuana enforcement, while still maintaining that advocates have gone too far in their pursuit of scaling back harsh sentencing laws. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — The congressman’s overall record on reform legislation is somewhat mixed. For example, he’s voted in favor of marijuana banking legislation, as well as a bill to reduce restrictions on carrying out cannabis research. The congressman is also a cosponsor of a bill to protect gun rights for medical cannabis patients this session, and he’s twice cosponsored legislation to automatically seal criminal records for people convicted of non-violent marijuana offenses. While he experienced a cannabis arrest himself, Donalds also voted against an amendment to prevent people from being denied security clearances over prior marijuana use—even though he’s able to receive classified briefings as a member of Congress regardless of his own history with cannabis. The congressman additionally voted against a bill to legalize marijuana in 2022. The post GOP Congressman Running For Florida Governor Admits To Selling Marijuana Despite Opposing Legalization And Sentencing Reform appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The governor of Oklahoma is repeating his call to roll back the state’s medical marijuana law, and he claims lawmakers are on board with putting the issue before voters again—despite recent comments from GOP leaders who’ve voiced skepticism about that possibility. In an interview with Family Research Center President Tony Perkins that was released on Wednesday, Gov. Kevin Stitt (R) was asked about his push to repeal Oklahoma’s medical cannabis program, which he’s described as necessary to combat youth use and the proliferation of unlicensed operators. Oklahomans were “sold a bill of goods” when medical marijuana was on the ballot in 2018 before he became governor, Stitt claimed. “They thought they were passing something that was going to help someone with chronic pain, and that was the only thing that could help them. But what actually happened is we have more dispensaries now than we have pharmacies.” “The industry is out of control. We grow 32 times more marijuana than actually is consumed legally, so we know it’s brought in cartel activity—Chinese influence, buying land,” he said. “It is not what Oklahomans thought that they were signing up for, and so I’m just asking the legislature, let’s send that back to a vote of the people.” The governor said part of the problem with the initial passage of medical cannabis legalization is that it’s “super easy to get something on the ballot in Oklahoma,” so the state has taken steps to make that process “a little more challenging and a little more representative.” One simpler way to get an issue on the ballot is through an act of the legislature, which he says is a possibility that’s actively under consideration. “We’ve got some great conversations with the House and the Senate. They know it’s a problem. Oklahomans all over are calling our offices saying it’s a problem,” Stitt said. “So I think we’ll get something back to the people. And, if we do, I think they’ll do the right thing and we’ll either remove it completely or we’ll actually regulate it properly.” Despite Stitt’s confidence in the legislature, his push for a medical cannabis rollback has drawn mixed reactions from lawmakers, including those within his own party. Senate President Pro Tempore Lonnie Paxton (R), for example, initially expressed openness to the idea—but he ultimately determined it’d be “really hard to completely undo” legalization and unfair to licensed medical cannabis operators who “invested their life savings into this program” and are “trying to do this for the Oklahomans that need that product—not for recreational, but for actual medicinal purposes.” “It’s hard to unring that bell,” he said. “What I’m going to suggest to the governor is that we don’t run a state question on that, but instead we continue to push the regulations [and] we continue to regulate the industry.” House Speaker Kyle Hilbert (R) has also largely dismissed the prospect of upending the state’s medical cannabis program. He said Oklahomans have already drawn a clear distinction: They support medical marijuana and “resoundingly” oppose adult-use legalization, based on past election results. Oklahoma Attorney General Gentner Drummond (R) was asked last month about the governor’s call to have voters revisit the state’s medical marijuana program, and he said he’d “love” to see the state’s medical marijuana program wiped out. However, he cautioned that doing so would mean reimbursing the hundreds of licensees participating in the market because the state would be “taking” a revenue source away from them. Meanwhile, Senate Minority Leader Julia Kirt (D) said she’s “not into revisiting state questions,” and lawmakers should “trust the people, and we should actually implement them as well.” “This legislature, before our time, could have made a decision to put guardrails in place before this state question passed,” the senator said. “Instead, they stuck their head in the sand and let that question pass and be mayhem.” Chris Anoatubby, the lieutenant governor of the Chickasaw Nation in Oklahoma, aligned himself with Stitt’s position, stating that the medical marijuana program as currently implemented has “been a problem all over Oklahoma.” He added that he’d “absolutely” support “reforming” the cannabis law. Notably, the governor also said this week that part of his problem with the state medical marijuana legalization movement is that cannabis remains federally prohibited, and he takes issue with the “checkered board of jurisdictions from these different states” with differing marijuana laws. The marijuana industry is out of control and harming our state. More dispensaries than pharmacies 32x more grown than consumed legally Staggering 73% rise in use among young people This isn’t what Oklahoma wanted or expected. Send it back to the people. https://t.co/Ds9RqsrJhP — Governor Kevin Stitt (@GovStitt) March 5, 2026 “It just creates all kinds of black market problems, and so I think it’s just overall bad. It’s a bad look. And again, think about that: More marijuana dispensaries in Oklahoma right now than we have pharmacies,” he said. “It makes no sense, and so I’m asking Oklahomans to retake a look at that.” “I’m just frightened by the amount of kids that are doing the gummies and doing these different things and the edibles,” he said. “We understand how harmful it is, and when you have legalized it, then young people think that it must be okay, but there’s just a lot of problems with this industry.” The governor also accepted the premise of the gateway drug theory, saying it’s “pretty common sense” that people who use cannabis could transition to more dangerous drugs. This has become a frequent talking point for Stitt, who similarly said this month that the state’s medical marijuana program has “failed,” and it’s “time to shut this broken system down” amid reports about youth cannabis use. The governor also said during a State of the State address last month that he wants voters who approved medical marijuana legalization at the ballot to revisit the reform. Back in 2022, Stitt similarly used his State of the State address as an opportunity to dig at the voter-approved medical marijuana law, arguing that residents were misled by proponents of the ballot initiative. Meanwhile, in November, Oklahoma activists withdrew an adult-use marijuana legalization initiative that they’d hoped to place on the state’s 2026 ballot. After a short but aggressive signature push to secure ballot placement, Oklahomans for Responsible Cannabis Action (ORCA) ultimately did not turn in its petitions by the deadline, according to the secretary of state’s office. ORCA said following the governor’s speech that the call for an end to the medical cannabis program is “simply an admission of his administration’s failure.” “While we were busy advocating for common sense regulation, his appointees were busy importing thousands of illegal [Chinese Communist Party] grows,” the group said.”Fortunately, the Feds picked up prosecution.. because they weren’t getting held accountable by the State.” “Fortunately, [Stitt] has no power here. It will take a vote of both the House and Senate to propose a vote to cancel SQ 788,” they said.”As we all move forward we must continue to be forward thinking, not backward acting. We look forward to talking and working with lawmakers, now and in the future.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, law enforcement leaders with the Oklahoma Association of Chiefs and Oklahoma Bureau of Narcotics and Dangerous Drugs have been raising concerns about cannabis. Also in Oklahoma, lawmakers last March advanced a bill aimed at protecting gun rights of state-registered medical marijuana patients, although federal law still bars cannabis users from owning firearms regardless of their patient status. Another state bill filed last year by a GOP legislator would criminalize the use of medical cannabis during pregnancy. Photo courtesy of Philip Steffan. The post Oklahoma Governor Claims Lawmakers Support His Push To Roll Back State’s Voter-Approved Medical Marijuana Law appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“I’ll note at the federal level that marijuana is still a controlled substance.” By Zach Wendling, Nebraska Examiner U.S. Sen. Pete Ricketts, R-Neb., sidestepped a question Wednesday about whether he would support adding Nebraska to a congressional list protecting state medical cannabis laws from federal interference after Congress left the state off the latest update in January. Ricketts, speaking on his weekly press call Wednesday, said he isn’t on the Senate Appropriations Committee, so he didn’t know why Nebraska was left off a list that currently covers 47 states. The other two not included are Kansas and Idaho, which lack medical cannabis programs. Other states on the list have less expansive laws than Nebraska voters approved in 2024. “I didn’t find out about it until it was raised in the press,” Ricketts said. U.S. Sen. Deb Fischer, R-Neb., is a member of Appropriations. Her staff did not return multiple requests for comment on the issue in February and again on Wednesday. Since 2014, Congress has prevented the U.S. Department of Justice and related agencies from using federal dollars to interfere with state medical marijuana programs. But despite Nebraskans approving two ballot measures to legalize and regulate the new medicine, national and state medical cannabis advocates say the Cornhusker State became the first not to be added in the dozen years since Congress first passed the provision as part of a spending bill. Nebraska voters legalized possession of up to 5 ounces of cannabis with a health care practitioner’s recommendation and created the regulatory Nebraska Medical Cannabis Commission. In February, Ricketts said he has “consistently expressed concern over the dangers of marijuana, especially for our youth” but respects “the will of Nebraskans and the process of the ballot amendments.” “If Nebraska’s laws are at odds with federal laws, a process will have to play out, and I will continue to express my concern for the risks of marijuana if it gets into the hands of kids,” Ricketts said February 16. His staff did not respond at the time to a follow-up question about whether Ricketts specifically opposed adding Nebraska to the federal list, as some advocates have alleged. President Donald Trump has called to downgrade the federal drug classification of marijuana, which could provide a path to more research or medicinal opportunities. Ricketts opposes the change. Asked by the Examiner on Wednesday whether Ricketts would support adding Nebraska to the federal medical cannabis noninterference list, he said his views on marijuana are “very clear.” “Whatever we’re doing needs to be following within the law,” said Ricketts, who, as a senator, can seek to change federal laws. “I’ll note at the federal level that marijuana is still a controlled substance.” This story was first published by Nebraska Examiner. Photo courtesy of Max Jackson. The post GOP Senator Dodges Question About Nebraska’s Exclusion From Medical Marijuana Protections At Federal Level appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

About one in three Americans who use CBD say they take it as an alternative or supplement to at least one medication—particularly painkillers—according to a new federally funded study. Researchers at the University of California, San Diego set out to better understand cannabidiol use trends, analyzing nationally representative survey data for the study, which was partially funded by the National Institute on Drug Abuse (NIDA) and published in the journal Frontiers in Public Health. Overall, about 35 percent of U.S. adults reported lifetime use of CBD, a non-intoxicating cannabinoid that’s grown in popularity since the federal legalization of hemp and its derivatives in 2018. The 1,008 CBD consumers who participated in the survey were asked about their frequency and methods of use, as well as whether they took the cannabis compound as a substitute or supplement to other traditional drugs. Among lifetime CBD consumers, 32 percent uses it as a substitute or adjunct for at least one medication, with adjunct usage being more common. “Millions of US adults use CBD as a substitute and adjunct for a wide range of health conditions.” For those who reported taking cannabidiol for therapeutic purposes, the “conditions most frequently targeted” were musculoskeletal and connective tissue disorders such as joint pain (10.1 percent), psychiatric disorders such as anxiety (7.4 percent) and general disorders or administration site conditions (6.8 percent. “Frequently replaced or co-administered medications included ibuprofen, Tylenol, and other over-the-counter analgesics,” the study authors said. “Only a small proportion of CBD ever users reported ever having a health problem they believed resulted from CBD use (2.4 percent).” “CBD use as a substitute or adjunct to medications was common among US adults particularly for pain medications,” they said. “These patterns underscore the need for better evidence and clearer guidance on dosing, product quality, and co-use with other treatments.” “A key finding is the widespread use of CBD in combination with prescription or over-the-counter medications, highlighting a potential for adverse drug–drug interactions,” the researchers noted. However, while questions remain as to the risk-benefit analysis of concurrent use of CBD with different drugs, “it needs also to be acknowledged that commonly prescribed medicines, e.g., psychotropics for anxiety or opioids for pain, also have potentially severe adverse effects and risk for forming,” the study says. “To the extent that CBD, which has very few side effects and likely very low risk of dependence at low to moderate doses, helps a consumer reduce anxiety and decrease or discontinue a medication with more side effects or risk for forming dependence, this might be viewed as a benefit,” it says. Currently, the Food and Drug Administration (FDA) has only approved a synthetic CBD drug for the treatment of severe epilepsy, “which should not be interpreted as proof of no therapeutic potential for other endpoints, but rather as reflecting in part the difficulty of generating regulatory-grade evidence in a landscape where cannabis has long been federally controlled and clinical research has faced substantial structural barriers,” the authors said. “Recent federal actions underscore this point,” they said, pointing out that, in December, President Donald Trump signed an executive order directing the federal reclassification of marijuana and laying out plans to incorporate CBD coverage under certain federal health insurance programs. The order “explicitly framed the gap between widespread medical use and limited clinical evidence as leaving patients and clinicians without adequate guidance, and directed agencies to reduce barriers and expand medical marijuana and CBD research, which hopefully will allow for rigorous clinical evaluation of CBD and medical cannabis for promising endpoints,” the study says. Meanwhile, although CBD was federally legalized during Trump’s first term under the 2018 Farm Bill, the availability of products could be jeopardized under separate legislation the president signed into law last year that included provisions that stakeholders say would effectively eradicate the cannabinoid market by severely restricting THC content. CBD isolates wouldn’t necessarily be impacted by the law that takes effect in November, but it’s relatively rare to find CBD such trace amounts of THC so as to meet the new federal definition of legal hemp. With respect to the latest cannabidiol study, it’s far from the only piece of research establishing that people are using marijuana and its constituents as an alternative to other drugs. To that point, another recent federally funded study, published by the American Medical Association (AMA), added more evidence that marijuana can serve as an effective substitute for opioids in chronic pain treatment. Other AMA-published research has found that legalizing marijuana for medical or recreational purposes is “significantly associated with reduced opioid use among patients diagnosed with cancer.” A separate paper published in October similarly found that medical marijuana legalization is “associated with significant reductions in opioid prescribing.” In August, meanwhile, Australian researchers published a study showing that marijuana can serve as an effective substitute for opioids in pain management treatment. Another study published earlier this year in the journal Drug and Alcohol Review found that, among drug users who experience chronic pain, daily cannabis use was linked to a higher likelihood of quitting the use of opioids—especially among men. Research published late last year also found that legalizing medical cannabis appeared to significantly reduce monetary payments from opioid manufacturers to doctors who specialize in pain, with authors finding “evidence that this decrease is due to medical marijuana becoming available as a substitute” for prescription painkillers. Other recent research also showed a decline in fatal opioid overdoses in jurisdictions where marijuana was legalized for adults. That study found a “consistent negative relationship” between legalization and fatal overdoses, with more significant effects in states that legalized cannabis earlier in the opioid crisis. Authors estimated that recreational marijuana legalization “is associated with a decrease of approximately 3.5 deaths per 100,000 individuals.” “Our findings suggest that broadening recreational marijuana access could help address the opioid epidemic,” that report said. “Previous research largely indicates that marijuana (primarily for medical use) can reduce opioid prescriptions, and we find it may also successfully reduce overdose deaths.” Another recently published report into prescription opioid use in Utah following the state’s legalization of medical marijuana found that the availability of legal cannabis both reduced opioid use by patients with chronic pain and helped drive down prescription overdose deaths statewide. Overall, results of the study indicated that “cannabis has a substantial role to play in pain management and the reduction of opioid use,” it said. The post Millions Of Americans Use CBD As A Substitute For Painkillers And Other Medications, Federally Funded Study Shows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A top GOP Tennessee lawmaker says medical marijuana legalization may move forward in the state now that his “biggest objections are being resolved” with the pending federal rescheduling of cannabis as ordered by President Donald Trump. While marijuana reform has long stalled in conservative legislature, House Majority Leader William Lamberth (R) said the push to move cannabis from Schedule I to Schedule III of the federal Controlled Substances Act (CSA) could remove roadblocks at the state level. “My biggest objections are being resolved by the federal government right now in rescheduling cannabis and rescheduling specifically marijuana and allowing the doctors to take over and make a determination on how and if these substances could be helpful,” Lamberth said. Rep. Jeremy Faison (R), who has worked to enact reform in the state, told WKRN-TV that he’d estimate “within the next two or three years, you’re going to see a framework set up here in Tennessee” to provide patients with a means to access cannabis for therapeutic use. “I look forward to the day in Tennessee that we’ve set up a framework where people aren’t just getting high, but there are some very sick people who don’t want to be on opiates or something that comes across from a prescription from the pharmacist,” the lawmaker said. “They want something natural—that’s safe—and we know where it came from and we know it’s not been perverted or filtrated with fentanyl or anything else.” “It’s going to happen soon,” Faison said, adding that the “federal government has realized that they’ve been in the way for a long time.” Senate Minority Leader Raumesh Akbari (D), for her part, said lawmakers “look at the opioid crisis” and “look at people who are addicted painkillers,” and they recognize marijuana “is an alternative” that the state “should have invested in a long time ago.” Lawmakers on both sides of the aisle in Tennessee similarly discussed how the federal move to reclassify marijuana could open the door to medical marijuana reform after Trump issued an executive order in December to see through the process. House Speaker Cameron Sexton (R) said at the time that rescheduling represents a “first step” to medical cannabis reform in Tennessee, though he noted there are still certain outstanding logistical questions to answer. “There will have to be conversations about who manufactures it, who tests it, who distributes, which medical illness could it be used for, does this require [federal Food and Drug Administration, or FDA] approval and a host of other questions,” Sexton said. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Sen. London Lamar (D), for her part, told WSMV that “if Washington can acknowledge reality, Tennessee can, too.” “Our marijuana laws are stuck in the dark ages—overly punitive, out of step with our neighbors and holding our state back,” she said. “It’s time for the General Assembly to take a serious step forward on cannabis reform.” “Cannabis reform is about freedom, public health and fiscal responsibility. We should be supporting medical researchers who want to study cannabis and patients who would choose cannabis treatments over deadly opioids,” Lamar said. “Our current laws force us to waste tax dollars on incarceration instead of investing in roads, schools and healthcare, and we’re also missing out on economic growth and new revenue.” The post Top GOP Tennessee Lawmaker Says Federal Marijuana Rescheduling Could Open Door To Legalizing Medical Use In His State appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Thanks for listing servers that prioritize quality-of-life features. Small conveniences like auto-party invites can improve retention. Real player reviews confirmed the value. สมัคร ufabet888

VA marijuana resentencing; OR & CO medical cannabis in healthcare facilities; UT psychedelics; MD firefighter marijuana protections Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there. Support our work at https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW The House and Senate Veterans Affairs Committees heard testimony from military veterans advocates about marijuana and psychedelics as alternative treatment options—including from one who discussed attending President Donald Trump’s cannabis rescheduling executive order signing ceremony. Virginia lawmakers sent Gov. Abigail Spanberger (D) legislation to provide resentencing relief for people with prior marijuana convictions, as bills to legalize recreational cannabis sales are also nearing the finish line. Oregon lawmakers sent Gov. Tina Kotek (D) a bill to allow patients to use medical cannabis in hospices and other healthcare facilities. Utah lawmakers sent Gov. Spencer Cox (R) a bill to support clinical trials into the efficacy of psychedelic-assisted therapy for military veterans with serious mental health conditions. The Maryland Senate passed a bill to protect firefighters and rescue workers from being penalized for off-duty use of medical cannabis, with the sponsor saying marijuana is a safer, viable alternative” to opioids. The Colorado House Health & Human Services Committee approved a Senate-passed bill to allow terminally ill patients to use medical cannabis in healthcare facilities such as hospitals, but advocates said recent changes undermine the intent. The Hawaii Senate Judiciary Committee approved a bill to allow patients to immediately purchase medical cannabis after their registration is submitted instead of having to wait until their card is delivered. The West Virginia House of Delegates passed a bill to allocate tens of millions of dollars in unspent medical cannabis revenue—with an amendment directing some of the funds to support research on the psychedelic ibogaine. An Oregon bill to ban marijuana edibles containing more than 10 milligrams of THC will not advance in the House of Representatives after being passed by the Senate. The South Dakota Senate Health and Human Services committee rejected a House-passed bill to eliminate the Medical Marijuana Oversight Committee, though it could potentially be revived by the full Senate. / FEDERAL The U.S. Court of Appeals for the Second Circuit ruled that medical cannabis can’t be reimbursed under federal workers’ compensation laws. The Congressional Research Service noted federal circuit court splits on challenges to residency requirements for marijuana business licenses. / STATES Kentucky Gov. Andy Beshear (D) announced that the state now has 19 operational licensed medical cannabis businesses. Maryland’s first lady testified in support of state legislation to address sales of kratom, 7-OH and other psychoactive substances Missouri’s state auditor published a report on marijuana taxes. The Georgia House of Representatives rejected a bill to tighten regulations for clinics that administer ketamine and other drugs used for psychedelic therapy. A former Kansas representative authored an op-ed calling on lawmakers to reform marijuana laws. California regulators announced a recall of marijuana products due to the presence of aspergillus. New York regulators approved additional marijuana business licenses and changes to medical cannabis rules. Massachusetts regulators extended for another three years the exclusivity period on marijuana delivery licenses for social equity and economic empowerment businesses. Washington State regulators are proposing changes to cannabis advertising rules. Michigan regulators are warning marijuana retailers to stop using the term “dispensary.” Ohio regulators posted updated marijuana business and sales data. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL The Covington, Georgia City Council rejected a marijuana decriminalization proposal. / INTERNATIONAL Grenada’s governor-general assented to the country’s cannabis reforms. The Isle of Man’s lieutenant governor visited a medical cannabis clinic. / SCIENCE & HEALTH A review concluded that “CBD and THC exert potent and multi-level anti-tumor effects in ovarian cancer models, driven by oxidative stress–mediated apoptosis and cell-cycle arrest.” A study found that “traditional Thai cannabis-based multi-herbal formulation demonstrated non-inferior efficacy to lorazepam and was well tolerated, supporting its use as a short-term alternative for chronic insomnia.” / BUSINESS AtaiBeckley Inc. reported quarterly revenue of $1.1 million and a net loss of $544.8 million. The Cannabist Company Holdings Inc. announced that an ad hoc group of noteholders of its senior secured notes and senior secured convertible notes agreed to a further extension and to forbear from exercising any of their rights and remedies governing the notes until March 17. / CULTURE Basketball player Dillon Brooks was arrested for suspicion of driving under the influence after police said his car “smells like a dispensary.” Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Max Jackson. The post Veterans push Congress on cannabis & psychedelics access (Newsletter: March 9, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

We service all of Hyderabad major neighborhoods, so you may reserve your call girl in Hyderabad by contacting the number below. Due to the exceptional quality of this solution, many clients in Hyderabad buy it from us. Call Girls in Delhi | Call Girls in Noida | Call Girls in Lucknow | Call Girls in Ajmer | Call Girls in Surat | Call Girls in Udaipur | Call Girls in Ranchi | Call Girls in Bhopal | Call Girls in Kochi | Call Girls in Coimbatore | Call Girls in Andheri | Call Girls in Indore | Call Girls in Nashik | Call Girls in Pushkar | Call Girls in Patna

The House had already passed the legislation, which could be revived by the full Senate. By Joshua Haiar, South Dakota Searchlight The committee that oversees South Dakota’s medical marijuana program should continue its work for at least another year, a panel of state senators decided. But the full Senate could have the final say. A bill that would repeal the sections of state law that established the Medical Marijuana Oversight Committee was rejected 4-3 in the Senate Health and Human Services Committee earlier this week, but a procedural effort is already underway to force it to the Senate floor next week. The bill passed the House of Representatives earlier, 41-26. Current law requires the Legislature’s Executive Board to appoint an 11-member committee made up of two senators, two representatives,and seven non-legislative stakeholders from an array of backgrounds, including medicine, law enforcement, counseling and at least one patient. The committee must meet at least twice a year and make recommendations to the Legislature and the Department of Health. The medical marijuana program itself would continue if the bill had passed, under the regulation of the state Department of Health. Rep. Tim Goodwin, R-Rapid City, introduced the bill. He said the committee made sense when the state was setting up the program after voters approved it in 2020, but that it has since become an unnecessary layer of bureaucracy. He said the Department of Health and the Legislature are equipped to manage the program going forward. The legislation comes amid friction between the oversight committee and the medical marijuana industry. In November, the committee approved 11 motions, primarily calling for tighter regulations, without publishing them in advance or taking public comment on each motion. The South Dakota Catholic Conference, South Dakota Sheriffs’ Association and the oversight committee’s current chair, Rep. Josephine Garcia, R-Watertown, all testified against the bill. Opponents said the oversight committee is a watchdog the public wants in place, and that the committee’s concerns have not yet been addressed. “We also have not determined, actually, the mental psychosis we’re now seeing, with cannabis use,” Garcia said. “Things that are being discussed are stress, anxiety, PTSD, which is not an indication for this type of cannabis use, and it has actually potentiated the mental psychosis.” The state has 18,306 medical marijuana patient cardholders. This story was first published by South Dakota Searchlight. The post South Dakota Bill To Eliminate Medical Marijuana Oversight Committee Fails In Senate Panel appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

When you use a genuine service, you will be able to provide instructions, share materials and choose the formatting style. pestoto

This is my first time visit to your blog and I am very interested in the articles that you serve. Provide enough knowledge for me. Thank you for sharing useful and don't forget, keep sharing useful info: pestoto

Thanks for the blog loaded with so many information. Stopping by your blog helped me to get what I was looking for. bandar slot

Founded in 1996 and built on the back of large industrial labour projects, we know our job like the back of our hands and combine over 200 years of industry knowledge across all our dedicated staff and range of services. We are partners with some of the biggest industry leaders around the world to ensure the highest standards, the largest range and the most cost-effective products are available to our clients.

I =appreciate how playlists like these allow people to relive past events or discover new music that fits a particular mood or community gathering. APM Roofing

“I thought that this fight was winnable. It’s a bill that does not cost the state a cent and that protects children from life-threatening overdoses of marijuana. I was wrong.” By Mia Maldonado, Oregon Capital Chronicle An attempt to limit how much THC can be in an individual edible isn’t advancing this year in Oregon. Senate Bill 1548 was an unsuccessful attempt to prevent the production of individual edibles with more than 10 milligrams of THC, targeting edibles that are meant to be divided into several servings. Sen. Lisa Reynolds, a Portland Democrat and pediatrician, introduced the bill in response to increasing reports of children seeking medical attention after consuming edibles resembling cookies, brownies and gummies. In 2023, children 5 and younger made up one-third of all cannabis-related cases reported to the Oregon Poison Center. Major medical groups supported the bill, and it passed the Senate in a bipartisan 22-5 vote. But it died in the House after marijuana industry lobbyists convinced House lawmakers to hold the bill, Reynolds said in a newsletter. “I thought that this fight was winnable,” Reynolds wrote. “It’s a bill that does not cost the state a cent and that protects children from life-threatening overdoses of marijuana. I was wrong.” Marijuana lobbyists argued the bill would create more plastic waste having to wrap each edible individually and that businesses wouldn’t have the money to buy machinery used to wrap individual edibles. Additionally, lobbyists said the bill would cost the state millions in tax revenue because it would eliminate popular marijuana products. Marijuana products in Oregon are taxed up to 20 percent depending on where they’re sold. Tax revenue from marijuana brought in $ $143.7 million in 2025, according to the Oregon Department of Revenue, and that revenue gets distributed to drug and treatment programs, public schools, mental health services, Oregon State Police and cities and counties across the state. Reynolds challenged those claims, saying the bill is based on Washington’s law that caps single servings of edibles at 10 milligrams of THC. When Washington enacted its law, the price of marijuana didn’t rise, she said. Plus, the law resulted in 75 percent fewer hospitalizations and half as many poisonings reported to poison centers, according to Dr. Julia Dilley, a Multnomah County epidemiologist. Reynolds chairs the Senate Early Childhood and Behavioral Health Committee, which in May heard from experts about how Oregon youth have some of the most elevated rates of cannabis use in the country, and yet they rank at the very bottom when it comes to recognizing the risks. Regulating marijuana in Oregon is of particular interest to Reynolds, who said she believes her brother’s habitual marijuana use in the ’70s contributed to his severe mental health problems as an adult and his regular admission into psychiatric hospitals. On the Senate floor on Thursday, she expressed support for a Republican resolution to urge Oregonians to refrain from using drugs including marijuana, though she voted against bypassing normal legislative procedures to bring that bill to the floor. Oregon youth are already experiencing more mental health challenges than adults, as youth suicide rates have consistently been higher than the U.S. rate. Reynolds said she plans to bring back more marijuana safety proposals in 2027 and will try to hire a lobbyist. This story was first published by Oregon Capital Chronicle. The post Oregon Bill To Ban Marijuana Edibles With More Than 10 Milligrams Of THC Fails appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“I don’t want to waste the money on something not dedicated to cannabis.” By Henry Culvyhouse, Mountain State Spotlight This story was originally published by Mountain State Spotlight. Get stories like this delivered to your email inbox once a week; sign up for the free newsletter at https://mountainstatespotlight.org/newsletter. Lawmakers cleared a key hurdle Wednesday to free millions of dollars in the state’s medical marijuana fund. In October, Mountain State Spotlight reported $34 million collected from fees and taxes from the medical marijuana program. The Treasurer’s Office said the money could not be spent due to the legal status of marijuana on the federal level, despite dozens of states already doing so. Del. Evan Worrell, R-Cabell, introduced a bill to spend the money. Lawmakers in the House of Delegates passed the bill 79-12 March 4, the last day for bills to leave their chamber of origin during the session. But before delegates took their vote, they took time to carve up what is now estimated to be nearly $38 million. Del. Michael Hite, R-Berkeley, successfully amended the bill to include $10 million each to West Virginia University and Marshall University for research into ibogaine, a hallucinogenic drug that is used in other countries to help people get through withdrawal. Earlier in the session, the House of Delegates unanimously passed a bill approving FDA trials on the drug in the state. Proponents of the amendment argued it was a case of the Legislature backing up a program with funding. But critics questioned the safety of ibogaine—which can cause cardiac arrest—or if the state should put it into pharmaceutical research. The measure passed 47-46. Worrell also amended the bill to put $5 million toward homeless services, stating he wanted to help that population after he unsuccessfully opposed passage of a public camping ban that effectively criminalizes unhoused people. That passed 59-34. Moving forward, the monies will go to Marshall University for research into marijuana WVU for substance disorder research, the Fight Substance Abuse Fund and grants for local law enforcement. Sen. Mike Woelfel, D-Cabell, said he was satisfied with how the money would initially be distributed under the original law passed in 2017. “I felt like we had a pretty good balance before, when we passed the bill that I wrote, so I’ll be anxious to look at those changes,” Woelfel said. “I don’t want to waste the money on something not dedicated to cannabis.” This article first appeared on Mountain State Spotlight and is republished here under a Creative Commons Attribution-NoDerivatives 4.0 International License. The post West Virginia House Passes Bill To Allocate Medical Marijuana Revenue, With Some Supporting Psychedelic Research appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I recently considered it could be a thought to create could someone else has been having troubles exploring yet I will be slightly not sure easily feel allowed to set brands and also address about the following. Estudiar Y Aprender

When i got onto your blog site though putting attention simply just a little bit submits. Pleasant strategy for future, I will be bookmarking at a time get ones finish springs up. สมัคร ufa356

Great post! I like how you spotlighted smaller, active communities. those often have the friendliest players and most cooperative environments. It’s cool to see which underrated servers are really thriving.IPTV Sverige

Colorado House lawmakers have approved a Senate-passed bill to allow terminally ill patients to use medical marijuana in healthcare facilities such as hospitals—though advocates have warned that recent amendments to the measure undermine its original intent. Weeks after advancing through the Senate, with amendments, the legislation from Sen. Kyle Mullica (D) cleared the House Health & Human Services Committee in a 10-2 vote on Thursday. It’s now been referred to the House Committee of the Whole before potentially moving to the floor. Reps. Sheila Lieder (D) and Lisa Feret (D) are sponsoring the bill on the House side, and they made the case for the reform before the committee took public testimony on the latest version, which was revised in the Senate to make it so hospitals could voluntarily elect to allow cannabis usage, rather than face a statutory requirement to do so. “This bill was brought to us from a patient perspective,” Lieder said on Thursday. “We want to ensure patients have a continuum of care when they are being treated in a hospital or health care facility.” “There’s been a lot of stakeholdering on this bill in the Senate. Several amendments were passed in the Senate committee without opposition,” she said. “That really brings us to a good place with the hospitals—mainly that participation is not mandated and it’s permissive.” Feret said the legislation “is a really great opportunity for people to have the autonomy to make a decision of how they want to spend their remaining days on this earth and how they want to treat their own pain and giving that autonomy to them.” “Some of the amendments that came through softened it a little bit, and some people are unhappy that it softened,” she said. “But that is the beauty of policymaking a compromise in this building is that we try to get to a good place.” Several advocates testified about those changes, arguing that making it hospitals would have the option—rather than a mandate—to allow medical cannabis use in their facilities would fundamentally undermine the intent of the reform. Jim Bartell, the father of a young California patient who passed and who inspired the policy that’s become known as Ryan’s law in his home state and several others, urged committee members to go back to original language of the bill and “use the original language of ‘shall’ and ‘must'” so that it doesn’t create a patchwork network of health facilities that permit or prohibit medical cannabis use. “For families like mine, this legislation is not theoretical. It’s part of ethical and compassionate care,” he said. Ken Sobel, an attorney with the Cannabis Nurses Network, said the “mandate is critically important because it’s the time that is lost in looking for a facility that allows the use of cannabis that literally compromises the ability to be with your close and loving family member.” “Changing ‘must’ or ‘shall’ to ‘may’ removes that core protection of Ryan’s law,” he said. Lieder, one of the bill sponsors, said in response to the testimony that she had just learned about the amendments that advocates are opposing. So while she moved to report the legislation out favorably, she said she will “gladly continue to work” with colleagues to address the issue. Under SB 26-007, health facilities would be permitted to develop guidelines for the use, storage and administration of medical marijuana. The Colorado Department of Public Health and Environment (CDPHE) would be prohibited from requiring compliance with the policy as a condition of obtaining or renewing a license or certification under the bill. Health facilities would be allowed to suspend the policy change if they risked enforcement action by a federal agency. “In FY 2026-27, workload in the Health Facilities and Emergency Medical Services Division in CDPHE will minimally increase to conduct outreach and education to licensed health care facilities regarding medical marijuana use,” a fiscal impact analysis says. “The department may also require legal services, provided by the Department of Law, related to rulemaking and implementation. This workload can be accomplished within existing appropriations.” Other amendments adopted in the Senate add additional compliance language, clarify that health facilities wouldn’t be required to store or dispense medical cannabis and limit legal liability for health institutions that permit medical marijuana use. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile in Colorado, the state saw over $1 billion in marijuana sales—a milestone the governor touted in December. Gov. Jared Polis (D) also said last month that his state should not have joined a lawsuit supporting the federal ban on gun ownership by people who use marijuana that recently went before the U.S. Supreme Court—and he personally opposes the state attorney general’s “legal position on this.” Photo courtesy of Max Jackson. The post Colorado Lawmakers Approve Bill To Allow Medical Marijuana Use In Hospitals By Terminally Ill Patients appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net